CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM – BioMarin Pharmaceutical Inc. Transaction History
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM portfolio value:
$112.32M
portfolio value
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.52% | -6.91K shares | 1.94M | $84.77 | 1.32M |
Q2 2022 | share | Decrease | -2.35% | -31.98K shares | 5.21M | $82.87 | 1.33M |
Q1 2022 | share | Decrease | -2.16% | -30.16K shares | -18.00M | $77.1 | 1.36M |
Q4 2021 | share | Decrease | -0.69% | -9.72K shares | 14.66M | $89.08 | 1.39M |
Q3 2021 | share | Increase | +8.28% | 107.35K shares | 325K | $77.29 | 1.40M |
Q2 2021 | share | Increase | +40.50% | 373.72K shares | 38.50M | $83.44 | 1.29M |
Q1 2021 | share | Decrease | -1.38% | -12.95K shares | -12.37M | $75.51 | 922.71K |
Q4 2020 | share | Increase | +2.82% | 25.68K shares | 12.81M | $87.69 | 935.67K |
Q3 2020 | share | Increase | +12.12% | 98.37K shares | -30.87M | $76.08 | 909.98K |
Q2 2020 | share | Increase | +102.36% | 410.53K shares | 66.21M | $123.34 | 811.61K |
Q1 2020 | share | Decrease | -5.64% | -23.96K shares | -2.04M | $84.5 | 401.08K |
Q4 2019 | share | Increase | +22.07% | 76.83K shares | 12.46M | $84.55 | 425.04K |
Q3 2019 | share | Increase | +28.51% | 77.24K shares | 261K | $67.4 | 348.21K |
Q2 2019 | share | Decrease | -3.61% | -10.15K shares | -1.76M | $85.65 | 270.96K |
Q1 2019 | share | Increase | +11.98% | 30.06K shares | 3.59M | $88.83 | 281.12K |
Q4 2018 | share | Decrease | -8.66% | -23.8K shares | -5.27M | $85.15 | 251.05K |
Q3 2018 | share | Decrease | -8.10% | -24.21K shares | -1.51M | $96.97 | 274.85K |
Q2 2018 | share | Decrease | -13.59% | -47.03K shares | 114K | $94.2 | 299.06K |
Q1 2018 | share | Decrease | -4.58% | -16.6K shares | -4.28M | $81.07 | 346.1K |
Q4 2017 | share | Increase | +9.08% | 30.2K shares | 1.39M | $89.17 | 362.7K |
Q3 2017 | share | Increase | +1.56% | 5.1K shares | 1.21M | $93.07 | 332.5K |
Q2 2017 | share | Increase | +2.22% | 7.1K shares | 1.61M | $90.82 | 327.4K |
Q1 2017 | share | Decrease | -4.13% | -13.8K shares | 439K | $87.78 | 320.3K |
Q4 2016 | share | Decrease | -4.84% | -17K shares | -4.80M | $82.84 | 334.1K |
Q3 2016 | share | Increase | +1.04% | 3.6K shares | 5.44M | $92.52 | 351.1K |
Q2 2016 | share | Decrease | -3.01% | -10.8K shares | -2.51M | $77.8 | 347.5K |
Q1 2016 | share | Decrease | -2.87% | -10.6K shares | -9.09M | $82.48 | 358.3K |